Deyaa Adib

Equibles does not estimate personal net worth.

About Deyaa Adib

Kyntra Bio, Inc. reported in an 8-K filed September 6, 2024 that Deyaa Adib was terminated as Chief Medical Officer, effective November 1, 2024.

“the Company provided notice of termination to two executive officers on August 30, 2024, each of whom will remain with the Company through a transition period: Juan Graham, Chief Financial Officer and Deyaa Adib, M.D., Chief Medical Officer.”

Kyntra Bio, Inc. Form 8-K, filed September 6, 2024 · Read the filing

Affiliation history

Kyntra Bio, Inc. (KYNB)
Proxy statement

Start not stated–2024-08-30
Kyntra Bio, Inc. (KYNB)
Proxy statement

Start not stated–2024-11-01

Company network

Kyntra Bio, Inc.

KYNB

Biotechnology · Healthcare

Recent activity

Executive change Terminated: Chief Medical Officer Kyntra Bio, Inc. (KYNB)
2024-11-01